Indian generics grab a strategic foothold in Japan
The recent announcement that Indian generic manufacturer Suven Life Sciences was granted four pharmaceutical patents in China, Mexico and New Zealand, adding to the five patents it holds in Japan, once again shows that Indian generics have steadily…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.